X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (80) 80
pseudoautosomal region (70) 70
genetics & heredity (69) 69
male (63) 63
index medicus (56) 56
female (52) 52
animals (36) 36
chromosomes (26) 26
recombination (25) 25
homeodomain proteins - genetics (24) 24
short stature (24) 24
in situ hybridization, fluorescence (23) 23
sex chromosomes (23) 23
short stature homeobox protein (23) 23
research (22) 22
genes (21) 21
genetics (21) 21
turner-syndrome (20) 20
adult (19) 19
biochemistry & molecular biology (19) 19
x-chromosome (19) 19
genomics (18) 18
shox (18) 18
mutation (17) 17
y-chromosome (16) 16
evolution, molecular (15) 15
gene (15) 15
leri-weill dyschondrosteosis (15) 15
genetic aspects (14) 14
growth disorders - genetics (14) 14
osteochondrodysplasias - genetics (14) 14
x chromosome (14) 14
y chromosome (14) 14
deletion (13) 13
idiopathic short stature (13) 13
x chromosome - genetics (13) 13
adolescent (12) 12
cell biology (12) 12
child (12) 12
chromosomes, human, x - genetics (12) 12
dyschondrosteosis (12) 12
evolution (12) 12
genomes (12) 12
meiosis (12) 12
chromosome mapping (11) 11
endocrinology & metabolism (11) 11
human sex-chromosomes (11) 11
mutations (11) 11
pseudoautosomal regions (11) 11
turner syndrome (11) 11
y chromosome - genetics (11) 11
analysis (10) 10
chromosome deletion (10) 10
chromosomes, human, y - genetics (10) 10
gene deletion (10) 10
homeobox (10) 10
human genome (10) 10
human x-chromosome (10) 10
pedigree (10) 10
physiological aspects (10) 10
recombination, genetic (10) 10
spermatogenesis (10) 10
deletions (9) 9
genetic research (9) 9
haploinsufficiency (9) 9
infertility (9) 9
sex chromosomes - genetics (9) 9
chromosomes, artificial, bacterial (8) 8
cytogenetics (8) 8
dosage compensation (8) 8
gene expression (8) 8
genetic linkage (8) 8
growth (8) 8
human genetics (8) 8
human y-chromosome (8) 8
karyotyping (8) 8
life sciences (8) 8
map (8) 8
phenotype (8) 8
polymerase chain reaction (8) 8
sex-chromosomes (8) 8
base sequence (7) 7
body height - genetics (7) 7
child, preschool (7) 7
chromosome (7) 7
dosage compensation, genetic (7) 7
evolutionary biology (7) 7
fish (7) 7
gene duplication (7) 7
genome (7) 7
infertility, male - genetics (7) 7
madelung deformity (7) 7
mice (7) 7
par (7) 7
polymorphism, single nucleotide (7) 7
pseudoautosomal region 1 (7) 7
research article (7) 7
shox gene (7) 7
biological evolution (6) 6
biotechnology & applied microbiology (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Si, N and Meng, XL and Zhao, Z and Xia, WB and Zhang, X
JOURNAL OF TRANSLATIONAL MEDICINE, ISSN 1479-5876, 04/2019, Volume 17
BackgroundGenomic disorders present a wide spectrum of unrelated clinical entities that result from genomic rearrangements. Interstitial insertions requiring... 
X-linked recessive | MEDICINE, RESEARCH & EXPERIMENTAL | SOX3 | Genu varum | Xq27 | 1 palindrome | SHOX | Interstitial insertion | Pseudoautosomal region 1 | MECHANISMS | REARRANGEMENTS
Journal Article
Human Heredity, ISSN 0001-5652, 07/2009, Volume 68, Issue 3, pp. 192 - 200
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2003, Volume 121, Issue 6, pp. 962 - 965
TNFα | B‐CLL | purine analogue | SCT | indwelling central venous catheter | α‐thalassaemia | rhesus monkeys | adverse drug reaction | CYP2D6 | immunophenotyping | stomatocytosis | MYC | biological assay | mutation screening | cyclophosphamide | eosinophilia | granulocyte colony‐stimulating factor receptor | large cell lymphoma | transferrin mutation | Campath‐1H | megakaryocytes | rottlerin | bone marrow biopsy | anaplastic lymphoma kinase | cerebrovascular accident | marrow | lymphoproliferative disorder | SV40 | internalization | drug resistance | blood groups | immunoplatelet count | treatment | acute GVHD | HMEC | SDF‐1 | ethnicity | fibrinogen | Bcl‐XL | primary immune deficiency | cDNA microarray | monoclonal | multicentric Castleman's disease | thromboxane A2 | venous | interferon‐alpha | rolling | extinction | myeloma | adhesion molecules | Bcl‐2 | enoxaparin | HPA‐1a | rituximab | ocular relapse | combination chemotherapy | macrocytosis | CD4+ T cells | blood | childhood acute lymphoblastic leukaemia | bone marrow | α‐granules | variant Philadelphia | macrophage depletion | autologous | 17‐allylamino‐geldanamycin (17‐AAG) | chlorodeoxyadenosine | diffuse large B‐cell lymphoma | plasma | serum | long‐term follow‐up | cord blood | thrombocytes | Flt3 ligand | polycythaemia vera | pp65 | aplastic anaemia | red | allogeneic bone marrow transplantation | bone marrow aspiration | transmission | thalidomide | therapy‐related AML | HRQoL | non‐SLE patients | growth factors | lymphoproliferative disease | blood cells | soluble | chromogenic assay | BH3 | consent | myeloproliferative disorder | Ikaros | T‐cell acti‐vation | transplantation | PCR | phospholipase C‐β2 deficiency | child | alloimmune thrombocytopenia | P‐selectin | ferritin | fluorescent SSCP | ACA IgG antibodies | lupus anticoagulant | platelet activation | hypereosinophilic syndrome | bisphosphonates | chronic lymphocytic leukaemia (CLL) | differential display | human | nonsense mutation | Th1/Th2 | haemochromatosis | translocation | factor VIIa | structure–activity relationships | lymphoma | acute leukaemia | stroke | PT‐derived fibrinogen (PT‐Fg) tests | denaturing HPLC | inherited thrombophilia | treatment‐related sepsis | iron | platelet | transfusion threshold | cancer | monoclonal antibody therapy | factor VIII | monoclonal antibodies | coronary artery disease | perforin | bleeding | daltaparin | pre‐emptive therapy | Jehovah's Witness | P‐glycoprotein | safingol | protease‐activated receptors | Toll‐like receptors 1, 2 and 4 | sickle cell disease | tumour immunology | soluble P‐selectin | fatigue | CD85j (ILT2) | dendritic cells | platelet transfusion | hereditary hyperferritinaemia–cataract syndrome | plasma exchange | AL amyloidosis | CA15·3 | stem cells | thrombopoietin | CML | angiogenesis | clonal | ganciclovir | classification | CMV | glycodelin | deferiprone | haemolytic anaemia | PAR1: pseudoautosomal region 1 | red cell transfusion | ABL‐BCR | cytotoxic drug | myelodysplastic syndromes | leukaemia | Wintrobe | killer Ig‐like receptors | porphyria cutanea tarda | enzymatic pathway | GVL | dog | reduced conditioning | acute myeloid leukaemia (AML) | BFU‐E | T‐LGL | CD14+ cells | fibrinogen assays | CYP2C19 | imatinib mesylate | HIES | TPO | myelodysplasia | tetramers | law of consent | tumour | N‐glycan analysis | haemophilia | IgE production | stochastic | juvenile myelomonocytic leukaemia | loss of heterozygosity | cyclosporine | cardiovascular disease | NK cells | proliferation | haemophagocytic lymphohistiocytosis | hepatocyte growth factor (HGF) | FANCC | cardiac contractility | thrombopoiesis | micro‐albuminuria | CDK6 | hydroxyurea | t(8;13) | clonogenic | coronary heart disease | JB‐1 | intracellular labelling | O‐PRISM score | FLT3 | transcription factors | asymptomatic carriers | polymorphism | non‐Hodgkin's lymphoma | systemic mastocytosis | LIP‐CLOD | iron metabolism | haematological malignancies | mutations | glycoprotein VI | NKG2A | genetic susceptibility | MGUS | chronic | MDS | neutrophils | AML | multiple myeloma | comparison | VWF | SQUID | cyclooxygenase | diagnosis | PKC | CFU‐GM | immuno‐electron microscopy | VWF‐cleaving protease | immunosuppressive therapy | clinical | paediatric cancer | MEL | tinzaparin | immunoperoxidase | VWF propeptide | gammopathies | differentiation | graft | monocyte–macrophage system | PTEN gene | apoptosis | haematology | allelic imbalance | von Willebrand | TGF‐β | TTP | CFU‐E | genetics | acquired factor X deficiency | touchdown | erythropoietin | dexamethasone | blood transfusion | blood platelets | prostacyclin | localized non‐Hodgkin's lymphoma | chronic myelogenous leukaemia | molecular remission | platelet counting | risk factor | intravenous immune globulin | chronic myeloid leukaemia | t(11;14) | radiation | TGFβ | monoclonal antibody | predisposition | GVHD | prognostic factors | cytogenetics | microsatellite markers | peripheral blood stem cell transplantation | sequencing | nomenclature | serotonin | cytomegalovirus | cord blood transplantation | death receptor | antigenaemia | B‐domain‐deleted recombinant factor VIII | pregnancy | cellular immunotherapy | C‐reactive protein | platelets | eye | clinical research | lymphocyte immunophenotype | pasteurization | VWD type 2A | carbohydrate sequence | refractory anaemia | T‐cell expansion | Tie‐2 | iron uptake | Gαq deficiency | graft type | tetramer | factor VIII:C | soluble cytokine receptors | anaplastic | inner and outer mitochondrial membrane | GM‐CSF | mesenchymal | allogeneic | endothelial | mantle cell lymphoma | anaplastic large cell lymphoma | CD30 | Fanconi anaemia | heat shock protein 90 (Hsp90) | Na+–K+–ATPase activity | childhood | collagen | adhesion | prognosis | cation leak | desferrioxamine | medical consent | ATG | human parvovirus B19 | cyclin D3 | FISH | mortality | CD27 | CD26 | minimal residual disease | myelodysplastic syndrome | extracellular matrix | oxidative stress | venous thrombosis | CD40 | pulmonary hypertension | family studies | Rai stage | MLL | research | WASP | heparin | 11q23 | overall survival | CD34 | coagulation factors | acquired | arachidonic acid | clinical trial | self‐renewal | IL‐1 | coronary | IgVH mutations | tumour suppressor gene | lymphocytic leukaemia | neutropenia | anti‐IgM | MAPK | parvovirus | tumorgenesis | megakaryocytopoiesis | p27Kip1 | platelet dysfunction | CD61 | T‐cell | sMUC‐1 | gene polymorphisms | ReFacto | leucotriene B4 | thrombosis | cytopenia | factor | folic acid | morbidity | immunoglobulin | Clauss assay | factor XI deficiency | respiratory infection | polymorphisms | dominant‐negative isoform | parvovirus B19 | chronic lymphocytic leukaemia | prostaglandins | risk | acquired APCR | stem | galactomannan | interleukin 15 | quantitative PCR | HFE | unfractionated heparin | p53 | paediatric | myelodysplastic | children | chronic anaemia | review | flow cytometry | childhood AML | splenectomy | Boston | prion protein | IFNγ | T lymphocytes | myelofibrosis | antibody | CD94 | darbepoietin | OGP10‐14 | anaemia of chronic disease | linkage mapping | resistance | chemoattraction | transcranial Doppler ultrasonography | iron chelation | bleeding disorder/bleeding diathesis | antiβ2GPI IgG antibodies | low‐molecular‐weight heparin | der deletion | endothelial cells | infection | M‐CSF | one‐stage assay | calcium mobilization | idiopathic throm‐bocytopenic purpura | scid mice | A‐bomb survivors | T cells | haematopoietic stem cell transplantation | bone marrow transplantation | unrelated donor | poliomyelitis | pyridoxine | EBV | HUVEC | gemtuzumab ozogamicin | older patients | cell cycle | Sri Lanka | Cox‐2 | TNF‐related apoptosis‐inducing drug | plasminogen activator inhibitors | HIT | familial Hodgkin's lymphoma | fibrinogen antigen | candidate genes | culture | venous thromboembolism | hematopoietic stem cells | incidence | red cells | endotoxin | paediatric intensive care unit | transmigration | alpha‐interferon | c‐KIT | T‐cell depletion | bone mineral density | interleukin 6 | ouabain action | DNA variations | Aurora2/BTAK/STK15 | serology | Rh factor | femoral neck | von Willebrand Factor | MUD | tumour necrosis factor alpha | aggressive non‐Hodgkin's lymphoma | ABO blood group/von Willebrand factor | graft‐versus‐leukaemia effect | receptors | non‐myeloablative transplant | hyaluronan | survival | history | CD38 expression | thrombin receptors | NKT cells | platelet factor 4 | complete remission | fludarabine | quality of life | acute | adult ALL | thalassaemia | Leri–Weill dyschondrosteosis | thrombocytopenia | CBF | 5‐lipoxygenase | Wiskott–Aldrich syndrome | diabetes mellitus | β‐thalassaemia | graft versus myeloma | splice site mutations | stem cell | acute myeloid leukaemia | interleukin | ADCC | anaemia | reduced‐intensity stem cell transplantation | endothelial cell | therapy | chromosome | VWF ristocetin co‐factor | lymphoproliferative | thrombotic thrombocytopenic purpura | BAL | efficacy | imatinib mesylate (STI571) | inv | aspergillosis | bryostatin | myelosuppression | CD34+ cells
Journal Article
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, ISSN 1552-4841, 07/2010, Volume 153B, Issue 5, pp. 1110 - 1114
Journal Article
Current Genomics, ISSN 1389-2029, 04/2007, Volume 8, Issue 2, pp. 129 - 136
Journal Article
Journal of Medical Genetics, ISSN 0022-2593, 08/2016, Volume 53, Issue 8, pp. 536 - 547
Journal Article